Literature DB >> 9669802

A comparison of staging systems for nasopharyngeal carcinoma.

J S Cooper1, R Cohen, R E Stevens.   

Abstract

BACKGROUND: The fifth edition of the American Joint Committee on Cancer staging manual defines new rules for classifying nasopharyngeal carcinoma. The authors tested the value of this new system by applying these rules retrospectively to their previously treated patients and comparing the results with those obtained using the fourth edition of the AJCC staging manual or the Ho staging system.
METHODS: Information from 107 patients who had biopsy-proven squamous cell carcinoma of the nasopharynx that was treated in a constant fashion with definitive-intent radiation therapy alone at one institution provided the data base for this analysis. The extent of disease of each patient was staged according to the rules of 1) the fourth edition of the AJCC staging manual, 2) the Ho staging system, and 3) the fifth edition of the AJCC staging manual.
RESULTS: The new system appears to be better than the two previous systems. It separated patients into cohorts of more equal size than did either of the other systems. It also correlated with outcome for the study population more appropriately than did the fourth edition of the AJCC staging manual or the Ho staging system.
CONCLUSIONS: The fifth edition of the AJCC staging manual appears to be an improvement over the previous AJCC or Ho staging systems for the staging of nasopharyngeal carcinoma.

Entities:  

Mesh:

Year:  1998        PMID: 9669802

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  The evolution of nasopharyngeal carcinoma staging.

Authors:  Rui Guo; Yan-Ping Mao; Ling-Long Tang; Lei Chen; Ying Sun; Jun Ma
Journal:  Br J Radiol       Date:  2019-07-12       Impact factor: 3.039

2.  Current management strategy of nasopharyngeal carcinoma.

Authors:  William I Wei; Dora L W Kwong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-03-30       Impact factor: 3.372

3.  Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome.

Authors:  Ching-Chih Lee; Tze-Ta Huang; Moon-Sing Lee; Shih-Hsuan Hsiao; Hon-Yi Lin; Yu-Chieh Su; Feng-Chun Hsu; Shih-Kai Hung
Journal:  Radiat Oncol       Date:  2010-03-11       Impact factor: 3.481

4.  Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma.

Authors:  Matthew E Spector; K Kelly Gallagher; Emily Bellile; Steven B Chinn; Mohannad Ibrahim; Serena Byrd; Eric J Chanowski; Heather M Walline; Jeffrey S Moyer; Mark E Prince; Gregory T Wolf; Carol R Bradford; Jonathan B McHugh; Kitrina Cordell; Thomas Carey; Francis P Worden; Avraham Eisbruch; Douglas B Chepeha
Journal:  Head Neck       Date:  2014-01-20       Impact factor: 3.147

5.  Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.

Authors:  Lei Zeng; Yun-Ming Tian; Xue-Ming Sun; Ying Huang; Chun-Yan Chen; Fei Han; Shuai Liu; Mei Lan; Ying Guan; Xiao-Wu Deng; Tai-Xiang Lu
Journal:  Strahlenther Onkol       Date:  2014-05-17       Impact factor: 3.621

6.  Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma.

Authors:  Jia-Ni Wang; Pan Hu; Mu-Sheng Zeng; Ren-Bin Liu
Journal:  Chin J Cancer       Date:  2011-11-04

7.  Prognostic value of cervical nodal tumor volume in nasopharyngeal carcinoma: Analysis of 1230 patients with positive cervical nodal metastasis.

Authors:  Fo-Ping Chen; Guan-Qun Zhou; Zhen-Yu Qi; Li Lin; Jiang Hu; Xiao-Ju Wang; Ying Sun
Journal:  PLoS One       Date:  2017-05-10       Impact factor: 3.240

8.  Assessment of clinical and therapeutic factors in patients with nasopharyngeal undifferentiated carcinoma.

Authors:  Helma Maria Chedid; Sergio Altino Franzi; Rogério Aparecido Dedivitis
Journal:  Braz J Otorhinolaryngol       Date:  2008 Jul-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.